Josh Silverman

Chief Executive Officer & Founder

2022 - Current

Chief Science Advisor

2022

CEO

2018 - 2022

Chief Technology Officer and Co-Founder

2011 - 2018

President and Founder

2010 - 2014

Scientific founder and phage supplier

2008 - 2012

Developed the initial science applications for catalytic phage-based material synthesis technology platform. Provided early biological material manufacturing and developed internal processes for scale-up. Helped to develop internal screening and biological QC approaches.

Vice President, Product Development

2008 - 2011

Director Process Development

2006 - 2008

Director - CMC

2003 - 2006

Scientist

2002 - 2003